Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients (RECAD-AF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by University of Utah
Sponsor:
Information provided by (Responsible Party):
Christopher McGann, University of Utah
ClinicalTrials.gov Identifier:
NCT01710254
First received: October 2, 2012
Last updated: January 23, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)